Skip to main content

Congress Park Capital LLC

Position in HRTX — Heron Therapeutics, Inc. /De/

CIK 1730945 SARATOGA SPRINGS, NY

Position in HRTX

as of Jun 30, 2026 · filed Jul 14, 2026
Position Value
$860,619
-$2,365,570 QoQ
Shares Held
2,016,447
-50.0% QoQ
Ownership
1.06%
of shares outstanding
% of Portfolio
0.31%
of 13F equity value
Holder Rank
#15
of 160 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in HRTX Over Time

Shares Held

Position Value (USD)

Derivatives in HRTX

reported options exposure · as of Dec 31, 2020
CallValue
$6,351
CallShares
300
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Congress Park Capital LLC holds $1,045,010 across 2 Biotechnology names. HRTX ranks #1 (82.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 HRTX
Heron Therapeutics, Inc. /De/
This page
2,016,447 $860,619

All Filings in HRTX

Export CSV
28 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $860,619 2,016,447
2026-03-31 $3,226,189 4,032,737
2025-12-31 $3,987,717 3,067,475
2025-09-30 $3,641,597 2,890,157
2025-06-30 $4,695,275 2,268,249
2025-03-31 $4,478,357 2,035,617
2024-12-31 $3,756,907 2,455,495
2024-09-30 $3,936,375 1,978,078
2024-06-30 $5,524,753 1,578,501
2024-03-31 $4,556,054 1,644,785
2023-12-31 $3,057,705 1,798,650
2023-09-30 $606,824 589,150
2023-06-30 $593,050 511,250
2023-03-31 $484,196 320,660
2022-12-31 $650,275 260,110
2022-09-30 $720,607 170,760
2022-06-30 $447,125 160,260
2022-03-31 $730,718 127,748
2021-12-31 $818,203 89,617
2021-09-30 $1,279,881 119,727
2021-06-30 $3,049,478 196,487
2021-03-31 $3,122,807 192,647
2020-12-31 $6,351 300
2020-12-31 $4,183,551 197,617
2020-09-30 $3,035,862 204,849
2020-06-30 $2,947,354 200,364
2020-03-31 $1,303,668 111,045
2020-03-31 $2,348 200